Collegium Pharmaceutical Inc. (COLL) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Collegium Pharmaceutical Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$23.23
+1.00% today
Market cap
$749M
Overall quality
60/100
Kronos AI 30-day
+12.6%
8 of 8 simulated paths end higher
Collegium Pharmaceutical Inc. (COLL) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $749M. It trades at $23.23, up 1.00% today, at 15.8 times earnings. Its overall quality score is 60 out of 100, ranked against the whole US market. 6 analysts' average target of $48.71 implies +109.7% from today's price. Kronos AI's 30-day forecast is +12.6% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $48.71 |
| Low – high | $43.00 – $60.00 |
| Analysts | 6 |
| Upside to average | +109.7% |
Kronos AI 30-day forecast
| Expected close | $25.89 (+12.6%) |
| Likely range | +8.5% … +20.2% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 76 |
| Solvency | 27 |
| Growth | 78 |
| Overall | 60 |
| P/E | 15.8 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.